Roche
Roche NimbleGen and Sigma-Aldrich Collaborate to Advance Epigenetic Research
Published in Cancer Weekly, May 5th, 2009
Roche NimbleGen and Sigma-Aldrich (Nasdaq:SIAL) have started a collaboration to further chromatin immunoprecipitation-on-microarray (ChIP-chip) research by aligning their two complementary technologies, Roche NimbleGen’s ChIP-chip high-density microarrays and GenomePlex by Sigma-Aldrich. Together, the platforms enable researchers to effectively study the entire genome for epigenetic interactions between DNA and DNA-binding proteins to determine regions of the genome that are transcriptionally active or repressed as well as the mechanisms that regulate these processes. Understanding the fundamental epigenomic and genomic regulatory pathways underlying normal cell growth and tissue...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2009-05-05)
More Articles from Cancer Weekly
- Brain Cancer
Study results from Brain Tumor Center provide new insights into brain cancer - Cancer Gene Therapy
Research conducted at University of Marburg, Medical Department has updated our knowledge about cancer gene therapy - Cancer Gene Therapy
Research reports on cancer gene therapy from I. Gentschev and colleagues provide new insights - Cancer Vaccines
Newly published study shows that re-treatment with Pegasys® (peginterferon alfa-2a) provides hepatitis C patients with a second chance for a cure - Cancer Vaccines
Reports from Baylor College of Medicine, College of Medicine describe recent advances in cancer vaccines - Cancer Vaccines
Researchers from University of Georgia report details of new studies and findings in the area of cancer vaccines - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
